The importance of todays news lies in the fact that In the Phase 1b study, the company was able to score patients using the New York Heart Association Quality of life test, and the average observed improvement was significantly better than typical standard of care therapies in use today.
Anybody who understands the importance of " significant" in todays FDA rulings also understands the significance of todays
You will not find this CONFIRMATION in prior press releases, it was "may lead to a significant increase in quality of life for the patient"
Again, ACTC had until now, no scientific proven results that the quality of live of the patients was significantly improved.
The company trying to raise money for Phase II trials, for sure met the request by potential partners to deliver this proven result of significance.
Now they can and I think they will get a partner.
In your dillusional view???
look at ebit and outstanding shares. You'll se why its at 6 cents and not 50 cents...
If they have to do thiis tstudy on their own where will the money come from???
canceling the SMD study? Issue more stock?
This whole thing is convulted...
News on a weekday, YES! 100% accuracy on that call, and I am calling it again. More news will come on a weekday... and I will go out on a limb here and guarantee more news before 2011
Mark this post!